Anti-Clozapine - (Clone CLO-1256) (C550-1.0mg)

Clozapine, a unique atypical antipsychotic, is primarily employed in the treatment of schizophrenia, particularly in cases resistant to other antipsychotic medications. Introduced in the 1970s, clozapine stands out due to its distinct mechanism of action, primarily antagonizing dopamine receptors, but also influencing other neurotransmitter systems, including serotonin, histamine, and adrenergic receptors. This broad-spectrum modulation contributes to its efficacy in managing symptoms. Notably, clozapine is associated with a risk of agranulocytosis, a potentially life-threatening reduction in white blood cell count. Due to this risk, regular blood monitoring, specifically complete blood cell counts, is crucial for individuals on clozapine therapy. These diagnostic tests are essential for detecting early signs of agranulocytosis, allowing for prompt intervention and ensuring the overall safety and effectiveness of clozapine treatment in patients with severe or treatment-resistant schizophrenia.